Silverarc Capital Management, LLC Cullinan Oncology, Inc. Transaction History

Silverarc Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$10.2 - $11.91 $363,283 - $424,186	35,616 Added 15.52%	265,032 $2.71 Million
Q4 2022 Feb 14, 2023	BUY	$9.72 - $13.62 $47,248 - $66,206	4,861 Added 2.16%	229,416 $2.42 Million
Q3 2022 Oct 28, 2022	BUY	$11.82 - $15.42 $135,516 - $176,790	11,465 Added 5.38%	224,555 $2.88 Million
Q2 2022 Jul 25, 2022	BUY	$7.31 - $13.55 $1.56 Million - $2.89 Million	213,090 New	213,090 $2.73 Million
Q3 2021 Nov 15, 2021	SELL	$22.56 - $29.68 $1.71 Million - $2.25 Million	-75,732 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$24.96 - $41.25 $1.89 Million - $3.12 Million	75,732 New	75,732 $1.95 Million

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Silverarc Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Silverarc Capital Management, LLC with notifications on news.